摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (1R,4S,5R)-1-hydroxy-4,5-[(2S,3S)-2,3-dimethoxybutan-2,3-dioxy]-3-oxo-cyclohexan-1-carboxylate | 183474-88-6

中文名称
——
中文别名
——
英文名称
methyl (1R,4S,5R)-1-hydroxy-4,5-[(2S,3S)-2,3-dimethoxybutan-2,3-dioxy]-3-oxo-cyclohexan-1-carboxylate
英文别名
methyl (1S,4S,5R)-1-hydroxy-4,5-<(2S,3S)-2,3-dimethoxybutan-2,3-dioxy>-3-oxo-cyclohexan-1-carboxylate;methyl (1S,3S,4S,6S,9R)-9-hydroxy-3,4-dimethoxy-3,4-dimethyl-7-oxo-2,5-dioxabicyclo[4.4.0]decane-9-carboxylate;methyl (2S,3S,4aR,6R,8aS)-6-hydroxy-2,3-dimethoxy-2,3-dimethyl-8-oxo-4a,5,7,8a-tetrahydrobenzo[b][1,4]dioxine-6-carboxylate
methyl (1R,4S,5R)-1-hydroxy-4,5-[(2S,3S)-2,3-dimethoxybutan-2,3-dioxy]-3-oxo-cyclohexan-1-carboxylate化学式
CAS
183474-88-6
化学式
C14H22O8
mdl
——
分子量
318.324
InChiKey
ULQATDCKHCGEFE-JHYOHUSXSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -0.8
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.86
  • 拓扑面积:
    101
  • 氢给体数:
    1
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    • 1
    • 2
    • 3
    • 4

反应信息

点击查看最新优质反应信息

文献信息

  • Inhibitor Ionization as a Determinant of Binding to 3-Dehydroquinate Synthase
    作者:Feng Tian、Jean-Luc Montchamp、J. W. Frost
    DOI:10.1021/jo960709h
    日期:1996.1.1
    phosphorylmethyl, phosphonoethyl, and phosphonomethyl groups in carbocyclic inhibitors of DHQ synthase. All but one of the carbocyclic inhibitors were synthesized via intermediacy of a 2,3-butane bisacetal-protected 3-dehydroquinic acid. Carbaphosphinate (K(i) = 20 x 10(-)(6) M) was a modest competitive inhibitor of DHQ synthase, while carbaacetate was a linear mixed-type inhibitor (K(i) = 3 x 10(-)(6) M, K(i)'
    在DHQ合酶的抑制剂中,膦酰基甲基和羧甲基一元酸与琥珀酰基,丙二酰基醚,丙二酰基和羟基丙二酰基二酸一起被酰基甲基,膦酰基乙基和膦酰基甲基取代。除一种抑制剂外,所有化合物均通过2,3-丁烷缩醛保护的3-奎尼酸中间体合成。氨基膦酸(K(i)= 20 x 10(-)(6)M)是DHQ合酶的中等竞争性抑制剂,而氨基甲酸则是线性混合型抑制剂(K(i)= 3 x 10(-)(6) )M,K(i)'= 20 x 10(-)(6)M)。氨基甲酸(K(i)= 5 x 10(-)(6)M),氨基甲酸醚(K(i)= 7 x 10(-)(6)M),氨基甲酸(K(i)= 0.7 x 10( -)(6)M)和氨基甲酸丙二酸(K(i)= 0.3 x 10(-)(6)M)均为竞争性抑制剂氨基甲酸是唯一未被DHQ合酶化的抑制剂
  • First diastereoselective synthesis of methyl caffeoyl- and feruloyl-muco-quinates
    作者:Rakesh Jaiswal、Michael H. Dickman、Nikolai Kuhnert
    DOI:10.1039/c2ob25124h
    日期:——
    We report on a diastereoselective synthesis of six derivatives of caffeoyl- and feruloyl-muco-quinic acids. All the muco-quinic acid derivatives were obtained in excellent yield in five steps starting from quinic acid, caffeic acid and ferulic acid. Allyl ether protection of trans-hydroxy cinnamic acids was here introduced to chlorogenic acids synthesis. We show that muco-quinic acid derivatives, which are formally diastereoisomers of chlorogenic acids, can be readily distinguished by their tandem mass spectra
    我们报告了一种非对映选择性合成咖啡酰基和阿魏酰基粘喹酸六种衍生物的方法。以奎宁酸、咖啡酸阿魏酸为起点,通过五个步骤获得了所有的黏稠奎宁酸衍生物,收率极高。这里将反式羟基肉桂酸烯丙基醚保护引入到绿原酸合成中。我们的研究表明,作为绿原酸非对映异构体的粘液喹酸生物可以通过串联质谱很容易地区分出来。
  • (1R,4S,5R)-3-Fluoro-1,4,5-trihydroxy-2-cyclohexene-1-carboxylic acid: the fluoro analogue of the enolate intermediate in the reaction catalyzed by type II dehydroquinases
    作者:Martyn Frederickson、Aleksander W. Roszak、John R. Coggins、Adrian J. Lapthorn、Chris Abell
    DOI:10.1039/b404535a
    日期:——
    The fluoro analogue of the enolate intermediate in the reaction catalyzed by type II dehydroquinases has been prepared from naturally occurring (-)-quinic acid over seven steps and has been shown to be the most potent inhibitor reported to date of the type II enzyme from Mycobacterium tuberculosis.
    由II型喹啉酶催化的反应中醇盐中间体类似物是由天然存在的(-)-奎宁酸经七个步骤制备的,已被证明是迄今为止报道的分枝杆菌II型酶最有效的抑制剂。结核。
  • Design, synthesis and evaluation of bifunctional inhibitors of type II dehydroquinase
    作者:Miguel D. Toscano、Martyn Frederickson、David P. Evans、John R. Coggins、Chris Abell、Concepción González-Bello
    DOI:10.1039/b301731a
    日期:——
    quinic acid, and were assayed against type I (Salmonella typhi) and type II (S. coelicolor) dehydroquinases. None of the analogues showed inhibition for type I dehydroquinase. Six of the analogues were shown to have inhibition constants in the micromolar to low millimolar range against the S. coelicolor type II dehydroquinase, while two showed no inhibition. The binding modes of the analogues in the active
    II型喹啉酶的抑制剂被设计为跨越晶体学研究中为抑制剂(1S,3R,4R)-1,3,4-三羟基-5-环己烯-1-羧酸甘油分子确定的两个不同的结合位点链霉菌天蓝色的酶。设计了许多化合物以结合两个配体的特征。这些类似物是由奎宁酸合成的,并针对I型(鼠伤寒沙门氏菌)和II型(天蓝色链霉菌)喹啉酶进行了分析。没有类似物显示出对I型喹啉酶的抑制。已显示六个类似物在微摩尔至低毫摩尔范围内对S. coelicolor II型喹啉酶具有抑制常数,而两个没有显示抑制作用。S的活性位点中类似物的结合模式。通过与GOLD1.2分子对接研究了coelicolor酶。这些研究表明了一种结合模式,其中环的晶体结构与(1S,3R,4R)-1,3,4-三羟基-5-环己烯-1-羧酸相似,并且侧链占据了一部分甘油结合口袋。
  • Conversion of (−)-3-Dehydroshikimic Acid into Derivatives of the (+)-Enantiomer
    作者:Martin G. Banwell、Alison J. Edwards、Michael Essers、Katrina A. Jolliffe
    DOI:10.1021/jo034689c
    日期:2003.8.1
    (-)-3-DHS (1), a compound available in large quantity through "engineering" of the shikimic acid pathway, has been converted over eight steps into the methyl ester, ent-2, of the (+)-enantiomer. Methyl (+)-shikimate (15) and its C-3 epimer (ent-5) have also been prepared by related means.
    (-)-3-DHS(1)是通过the草酸途径的“工程化”而大量获得的化合物,经八步转化为(+)-对映体的甲ent-2。(+)-shi草酸(15)及其C-3差向异构体(ent-5)也已通过相关方法制备。
查看更多